Cargando…
Galectin-3 Is a Potential Mediator for Atherosclerosis
Atherosclerosis is a multifactorial chronic inflammatory arterial disease forming the pathological basis of many cardiovascular diseases such as coronary heart disease, heart failure, and stroke. Numerous studies have implicated inflammation as a key player in the initiation and progression of ather...
Autores principales: | Gao, Ziyu, Liu, Zhongni, Wang, Rui, Zheng, Yinghong, Li, Hong, Yang, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042544/ https://www.ncbi.nlm.nih.gov/pubmed/32149158 http://dx.doi.org/10.1155/2020/5284728 |
Ejemplares similares
-
Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study
por: Liu, Zhongni, et al.
Publicado: (2018) -
Spatial and Temporal Expression, and Statin Responsiveness of Galectin-1 and Galectin-3 in Murine Atherosclerosis
por: Lee, Yong-Jin, et al.
Publicado: (2013) -
Galectin-9: A Suppressor of Atherosclerosis?
por: Yu, Jian, et al.
Publicado: (2020) -
ROS-Dependent Activation of Autophagy through the PI3K/Akt/mTOR Pathway Is Induced by Hydroxysafflor Yellow A-Sonodynamic Therapy in THP-1 Macrophages
por: Jiang, Yueqing, et al.
Publicado: (2017) -
Galectin-3 Identifies a Subset of Macrophages With a Potential Beneficial Role in Atherosclerosis
por: Di Gregoli, Karina, et al.
Publicado: (2020)